|
BOARD OF DIRECTORS
Hampar Karageozian, Ph.D, MBA
Hampar Karageozian is a co-founder of Vitreoretinal Technologies, Inc. and serves as the company's CEO. He has over 35 years of experience in ophthalmic research, development, manufacturing, regulatory and marketing. As Senior VP of Research and Development at Allergan Pharmaceuticals, he managed a budget of over $100 million and was directly involved in the development and launch of more than 50 products during his 23-year tenure. His responsibilities included the expansion of Allergan's presence in both the European and Japanese markets. Mr. Karageozian was a co-founder, Senior VP of R&D and CTO of ISTA Pharmaceuticals. In addition, he is a prolific inventor with over 25 domestically and internationally issued patents.
Vicken Karageozian, MD
Vicken Karageozian is a co-founder of Vitreoretinal Technologies, Inc. and serves as Chief Technology Officer and Chief Medical Officer. He is a Board Certified ophthalmic surgeon. He is an Assistant Clinical Professor of Ophthalmology at University of California, Irvine. Dr. Karageozian graduated from the University of California, San Diego with double majors in biochemistry and economics. He received his MD from Tufts University in Boston and completed his ophthalmic training at the University of California, Irvine. He has over 10 years experience in ophthalmic drug development with such companies as Allergan Pharmaceuticals and ISTA Pharmaceuticals. He has been involved with several successful startup companies. He has numerous U.S. and international patents. His particular experience and strengths relate to pharmaceuticals of the posterior segment of the eye.
Ramgopal Rao, MSEE, MBA
Ramgopal Rao serves as Chief Operating Officer for Vitreoretinal Technologies, Inc. He is an entrepreneur with 25 years of experience in the ophthalmic market and has worked with several successful startup companies. Mr Rao most recently developed a corneal implant device for presbyopia which is licensed to (venture funded) Acufocus, Inc. He founded Tomey Technology, Inc., an ophthalmic imaging instrumentation company that grew to $50 million sales volume in four years. Tomey pioneered the corneal topography mapping systems that are now a standard in eye care. Mr. Rao was a President of the Ophthalmic Group at Premier Laser Systems, Inc., which is a publicly-held company. He holds a MSEE from Oklahoma State University and an MBA from Northeastern University.
Frederick Dotzler
Fred Dotzler co-founded De Novo Ventures in 2000, a venture capitalist company. Prior to De Novo, he was a Managing General Partner of Medicus Venture Partners, which he founded in 1989. He served in executive positions in finance, marketing, sales, manufacturing and business development for companies selling pharmaceuticals, medical instruments, biotechnology research tools, and computers.
David Fancher
David Fancher is vice president of global sales at contact lens manufacturer SynergEyes. He has more than 14 years of global and national sales and marketing experience in the eye care industry. From 2005 until his retirement in 2006, Mr. Fancher was president of CooperVision Surgical, a division launched by the Cooper Companies, focusing on corneal and refractive surgery. Prior to that position, Mr. Fancher was senior vice president of sales for CooperVision.
Robert Roe, MD
Robert Roe joined Corcept as President in October 2001. Dr. Roe has spent more than 30 years in the pharmaceutical and biotechnology industries. From 1999 to 2001, he served as President and Chief Executive Officer of Allergenics, Inc. From 1996 to 1999, Dr. Roe was Executive Vice President, Chief Operating Officer and a director of Cytel Corporation. From 1995 to 1996, he was Executive Vice President, Chief Operating Officer and a director of Chugai Biopharmaceuticals, Inc. From 1992 to 1995, Dr. Roe served as President of the Development Research Division and Senior Vice President of Syntex Corporation. Dr. Roe received his AB from Stanford University and his MD from the University of California, San Francisco. |
